相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Auranofin: Past to Present, and repurposing
Masamichi Yamashita
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Targeting Redox Metabolism in Pancreatic Cancer
Nadine Abdel Hadi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models
Mayrim V. Rios Perez et al.
SURGERY OPEN SCIENCE (2019)
Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent
Edmund V. Capparelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
Hui Wang et al.
ONCOTARGET (2017)
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
Javier Martinez-Useros et al.
JOURNAL OF CLINICAL MEDICINE (2017)
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
Judith G. Villablanca et al.
PEDIATRIC BLOOD & CANCER (2016)
Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism
Samuel N. Rodman et al.
RADIATION RESEARCH (2016)
Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma
Prahlad V. Raninga et al.
REDOX BIOLOGY (2016)
Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues
Qing Chang et al.
SCIENTIFIC REPORTS (2016)
Reactive Oxygen Species in Cancer: A Dance with the Devil
Paul T. Schumacker
CANCER CELL (2015)
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
Traver Hart et al.
CELL (2015)
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder et al.
DRUGS IN R&D (2015)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Thioredoxin Reductase and its Inhibitors
Fulvio Saccoccia et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
A. Tagde et al.
BLOOD CANCER JOURNAL (2014)
Oxidative stress and cancer: An overview
Venus Sosa et al.
AGEING RESEARCH REVIEWS (2013)
Glutathione synthesis
Shelly C. Lu
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer
Bingbing Dai et al.
CANCER RESEARCH (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation
Therese Christina Karlenius et al.
Cancers (2010)
On the potential of thioredoxin reductase inhibitors for cancer therapy
Sabine Urig et al.
SEMINARS IN CANCER BIOLOGY (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
分享论文
